tirzepatide glp1 gip Microdosed GLP-1 use tripled among non-diabetics,

Thyroid cancer In toxicology studies, a dose-dependent and treatment-duration-dependent increase in the incidence of malignant and benign thyroid medullary tumors (C-cell tumors) was observed in rats treated with clinically relevant doses of tirzepatide

Monthly or even quarterly depot injections of GLP-1 agonists are in development

Imagine your thigh divided into three equal horizontal sections

In the SURMOUNT-1 clinical trial, participants on the highest dose achieved 22.5% body weight reduction over 72 weeks

Write down which site you used each week

Patients building muscle through exercise while losing fat may see the scale stall while measurements continue improving